These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 18850582

  • 1. SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.
    Hrzenjak A, Kremser ML, Strohmeier B, Moinfar F, Zatloukal K, Denk H.
    J Pathol; 2008 Dec; 216(4):495-504. PubMed ID: 18850582
    [Abstract] [Full Text] [Related]

  • 2. Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.
    Quan P, Moinfar F, Kufferath I, Absenger M, Kueznik T, Denk H, Zatloukal K, Haybaeck J.
    Anticancer Res; 2014 Jun; 34(6):2883-97. PubMed ID: 24922651
    [Abstract] [Full Text] [Related]

  • 3. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D, Ong JM, Hu J, Desmond JC, Kawamata N, Konda BM, Black KL, Koeffler HP.
    Clin Cancer Res; 2007 Feb 01; 13(3):1045-52. PubMed ID: 17289901
    [Abstract] [Full Text] [Related]

  • 4. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 01; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 5. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D.
    Int J Oncol; 2007 Sep 01; 31(3):633-41. PubMed ID: 17671692
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
    Wu Y, Guo SW.
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr 01; 137(2):198-203. PubMed ID: 17376583
    [Abstract] [Full Text] [Related]

  • 7. Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells.
    Hrzenjak A, Moinfar F, Kremser ML, Strohmeier B, Staber PB, Zatloukal K, Denk H.
    Mol Cancer Ther; 2006 Sep 01; 5(9):2203-10. PubMed ID: 16985053
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan 01; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 9. SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.
    Komatsu N, Kawamata N, Takeuchi S, Yin D, Chien W, Miller CW, Koeffler HP.
    Oncol Rep; 2006 Jan 01; 15(1):187-91. PubMed ID: 16328054
    [Abstract] [Full Text] [Related]

  • 10. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
    Munster PN, Troso-Sandoval T, Rosen N, Rifkind R, Marks PA, Richon VM.
    Cancer Res; 2001 Dec 01; 61(23):8492-7. PubMed ID: 11731433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
    Rikiishi H, Shinohara F, Sato T, Sato Y, Suzuki M, Echigo S.
    Int J Oncol; 2007 May 01; 30(5):1181-8. PubMed ID: 17390020
    [Abstract] [Full Text] [Related]

  • 15. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T, Takai N, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2007 Feb 01; 19(2):301-8. PubMed ID: 17203205
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway.
    Tsapis M, Lieb M, Manzo F, Shankaranarayanan P, Herbrecht R, Lutz P, Gronemeyer H.
    Int J Biochem Cell Biol; 2007 Feb 01; 39(7-8):1500-9. PubMed ID: 17499001
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.